These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 19162489)
1. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. Khoshneviszadeh M; Edraki N; Javidnia K; Alborzi A; Pourabbas B; Mardaneh J; Miri R Bioorg Med Chem; 2009 Feb; 17(4):1579-86. PubMed ID: 19162489 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents. Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents. Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines. Sirisha K; Bikshapathi D; Achaiah G; Reddy VM Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653 [TBL] [Abstract][Full Text] [Related]
5. Facile synthesis and antibacterial, antitubercular, and anticancer activities of novel 1,4-dihydropyridines. Sirisha K; Achaiah G; Reddy VM Arch Pharm (Weinheim); 2010 Jun; 343(6):342-52. PubMed ID: 20496343 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents. Desai NC; Trivedi AR; Somani HC; Bhatt KA Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives. Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815 [TBL] [Abstract][Full Text] [Related]
9. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
10. Ring-substituted imidazoles as a new class of anti-tuberculosis agents. Gupta P; Hameed S; Jain R Eur J Med Chem; 2004 Sep; 39(9):805-14. PubMed ID: 15337293 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Ali MA; Shaharyar M; Siddiqui AA Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-α and IL-6 with anti-tubercular activity. Upadhyay K; Bavishi A; Thakrar S; Radadiya A; Vala H; Parekh S; Bhavsar D; Savant M; Parmar M; Adlakha P; Shah A Bioorg Med Chem Lett; 2011 Apr; 21(8):2547-9. PubMed ID: 21396814 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo[2,1-b]-1,3,4-thiadiazole derivatives. Gadad AK; Noolvi MN; Karpoormath RV Bioorg Med Chem; 2004 Nov; 12(21):5651-9. PubMed ID: 15465343 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q; Luo H; Chen Y; Wang T; Yao Q Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Shingalapur RV; Hosamani KM; Keri RS Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630 [TBL] [Abstract][Full Text] [Related]
17. Selective one-pot multicomponent synthesis and anti-tubercular evaluation of 5-(aryl/cyclohexylsulfanyl)-2-alkoxy-4,6-diarylnicotinonitriles. Manikannan R; Muthusubramanian S; Yogeeswari P; Sriram D Bioorg Med Chem Lett; 2010 Jun; 20(11):3352-5. PubMed ID: 20434911 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis. Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives. Horita Y; Takii T; Kuroishi R; Chiba T; Ogawa K; Kremer L; Sato Y; Lee Y; Hasegawa T; Onozaki K Bioorg Med Chem Lett; 2011 Feb; 21(3):899-903. PubMed ID: 21232949 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents. Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]